Tailor-made vaccines could almost halve rates of serious bacterial disease

New research has found that rates of disease caused by the bacterium Streptococcus pneumoniae could be substantially reduced by changing our approach to vaccination. Researchers combined genomic data, models of bacterial evolution and predictive modelling to identify how vaccines could be optimized for specific age groups, geographic regions and communities of bacteria.